Muscular atrophy, cholesterol and migraine medications added to PBS

The Australian

1 August 2021 - Australians living with chronic health conditions will save up to $123,000 per year with the addition of three new medications on the Pharmaceutical Benefits Scheme.

Patients suffering from spinal muscular atrophy, high cholesterol and chronic migraines will now have access to the medications Evrysdi, Praluent and Ajovy at an affordable price.

Read The Australian article

Michael Wonder

Posted by:

Michael Wonder